Completes repurchase of 400,000 shares of common stock, or 5% of shares previously outstanding, under a plan initiated last spring ("The Gray Sheet" May 10, 1993, p. 14). The firm plans to repurchase an additional 400,000 shares "through open market purchases from time to time as Hycor management deems appropriate." As of Jan. 6, about 8 mil. shares were outstanding
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
The Cancer Research Horizons Innovation Awards took place on July 10. Medtech Insight spoke to nominees for the women’s entrepreneur of the year award: Mireia Crispin-Ortuzar, CEO of 52 North Health; Anita Grigoriadis, CEO of PharosAI; and Maria Giovanna Lizio, Founder of WILD-Imaging Technology.
AI heart imaging company HeartFlow filed for a $100m IPO after scrapping its 2022 SPAC plans. It remains unprofitable but is betting on FDA clearances, Medicare coverage and a demand for AI-powered diagnostics to win over investors.
A federal court in Illinois ruled against SurModics and BC Holdings' request for FDA documents to support a proposed merger. The FTC has challenged the merger, claiming it threatens competition in hydrophilic device coatings. The ruling may indicate the FTC is likely to succeed.